Interleukin-17A promotes aortic endothelial cell activation via transcriptionally and post-translationally activating p38 mitogen-activated protein kinase (MAPK) pathway

Journal of Biological Chemistry

Volumn 291, Issue 10, 2016, Pages 4939-4954

  Mai, Jietang ^a   Nanayakkara, Gayani ^a   Lopez Pastrana, Jahaira ^a   Li, Xinyuan ^a   Li, Ya Feng ^a   Wang, Xin ^a   Song, Ai ^a   Virtue, Anthony ^a   Shao, Ying ^a   Shan, Huimin ^a   Liu, Fang ^a   Autieri, Michael V ^a   Kunapuli, Satya P ^a   Iwakura, Yoichiro ^b   Jiang, Xiaohua ^a   Wang, Hong ^a   Yang, Xiao Feng ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; BLOOD VESSELS; BODY FLUIDS; CELL ADHESION; CHEMICAL ACTIVATION; DATA MINING; ENZYME ACTIVITY; ENZYMES; IMMUNOLOGY; LIPOPROTEINS; MACROPHAGES; MAMMALS; MOLECULES; PROTEINS;

ADHESION MOLECULES; APOLIPOPROTEIN E (APOE); GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTORS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE ADHESION; OXIDIZED LOW-DENSITY LIPOPROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASE; PRO-INFLAMMATORY CYTOKINES;

ENDOTHELIAL CELLS;

APOLIPOPROTEIN E; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN; IL17A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; AORTA ENDOTHELIUM; ARTICLE; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ADHERENCE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; AORTA; C57BL MOUSE; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; AORTA; APOLIPOPROTEINS E; CELL ADHESION; CELLS, CULTURED; CHEMOKINE CXCL1; ENDOTHELIAL CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPERLIPIDEMIAS; INTERLEUKIN-17; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, INTERLEUKIN-17;

EID: 84964661046     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.690081     Document Type: Article

References (49)

1. Libby, P., and Ridker., P. M., and Hansson, G.K. (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325
2. Sha, X., Meng, S., Li, X., Xi, H., Maddaloni, M., Pascual, D. W., Shan, H., Jiang, X., Wang, H., and Yang, X. F. (2015) Interleukin-35 inhibits endothelial cell activation by suppressing MAPK-AP-1 pathway. J. Biol. Chem. 290, 19307-19318
3. Yin, Y., Li, X., Sha, X., Xi, H., and Li., Y. F., Shao, Y., Mai, J., Virtue, A., Lopez-Pastrana, J., Meng, S., and Tilley., D. G., Monroy, M. A., Choi, E. T., and Thomas., C. J., Jiang, X., Wang, H., and Yang, X. F. (2015) Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway. Arterioscler. Thromb. Vasc. Biol. 35, 804-816
4. Lopez-Pastrana, J., Ferrer, L. M., and Li., Y. F., Xiong, X., Xi, H., Cueto, R., Nelson, J., Sha, X., Li, X., and Cannella., A. L., Imoukhuede, P. I., Qin, X., Choi, E. T., Wang, H., and Yang, X. F. (2015) Inhibition of caspase-1 activation in endothelial cells improves angiogenesis: a novel therapeutic potential for ischemia. J. Biol. Chem. 290, 17485-17494
5. Cheng, Z., Jiang, X., Pansuria, M., Fang, P., Mai, J., Mallilankaraman, K., Gandhirajan, R. K., Eguchi, S., Scalia, R., Madesh, M., Yang, X., and Wang, H. (2015) Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation. Diabetes 64, 947-959
6. Shao, Y., Cheng, Z., Li, X., Chernaya, V., Wang, H., and Yang, X. F. (2014) Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction - a novel mechanism for maintaining vascular function. J. Hematol. Oncol. 7, 80
7. Mestas, J., and Ley, K. (2008) Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc. Med. 18, 228-232
8. Jiang, X., Yang, F., Tan, H., Liao, D., and Bryan., R. M., Jr., Randhawa, J. K., Rumbaut, R. E., Durante, W., Schafer, A. I., Yang, X., and Wang, H. (2005) Hyperhomocystinemia impairs endothelial function and eNOS activity viaPKC activation. Arterioscler. Thromb. Vasc. Biol. 25, 2515-2521
9. Zhang, D., Jiang, X., Fang, P., Yan, Y., Song, J., Gupta, S., Schafer, A. I., Durante, W., and Kruger., W. D., Yang, X., and Wang, H. (2009) Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine β-synthase-deficient mice. Circulation 120, 1893-1902
10. Fang, P., Zhang, D., Cheng, Z., Yan, C, Jiang, X., and Kruger., W. D., Meng, S., Arning, E., Bottiglieri, T., and Choi., E. T., Han, Y., Yang, X. F., and Wang, H. (2014) Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis. Diabetes 63, 4275-4290
11. high regulatory T cells aggravates cuff-injured vascular inflammation. Atherosclerosis 203, 401-408
12. Ait-Oufella, H., Salomon, B. L., Potteaux, S., and Robertson., A. K., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., and Flavell., R. A., Hansson, G. K., Klatzmann, D., Tedgui, A., and Mallat, Z. (2006) Natural regulatory t cells control the development of atherosclerosis in mice. Nat. Med. 12, 178-180
13. Yang, W. Y., Shao, Y., Lopez-Pastrana, J., Mai, J., Wang, H., and Yang, X. F. (2015) Pathological conditions re-shape physiological Tregs into pathological Tregs. Burns Trauma 3, 1
14. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 6, 1123-1132
15. Mai, J., Virtue, A., Maley, E., Tran, T., Yin, Y., Meng, S., Pansuria, M., Jiang, X., Wang, H., and Yang, X. F. (2012) MicroRNAS and other mechanisms regulate interleukin-17 cytokines and receptors. Front. Biosci. 4, 1478-1495
16. Arca, M., Quagliarini, F., Pigna, G., Catalano, C, and Napoli, A. (2011) Severe coronary and extracoronary atherosclerosis in autosomal recessive hypercholesterolemia detected by whole-body computed tomography angiography. Intern. Emerg Med. 6, 571-573
17. Szypula, I., Kotulska, A., Szopa, M., Pieczyrak, R., and Kucharz, E. J. (2009) Adiposis dolorosa with hypercholesterolemia and premature severe generalized atherosclerosis. Wiad. Lek. 62, 64-65
18. Rocha, V. Z., and Chacra., A. P., Salgado, W., Miname, M., Turolla, L., Gagliardi, A. C, Ribeiro, E. E., and Rocha., R. P., Avila, L. F., Pereira, A., Nakandakare, E. R., and Santos, R. D. (2013) Extensive xanthomas and severe subclinical atherosclerosis in homozygous familial hypercholesterolemia. J. Am. Coll. Cardiol. 61, 2193
19. Zhang, S. H, Reddick, R. L., and Piedrahita., J. A., and Maeda, N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoproteine. Science 258, 468-471
20. Mueller, M. A., Beutner, F., Teupser, D., Ceglarek, U., and Thiery, J. (2008) Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia. Atherosclerosis 198, 39-48
21. Dervisoglu, E., Turgut, T., and Yilmaz, A. (2007) Analbuminemia presentingwith severe hypercholesterolemia: a risk for atherosclerosis? Acta Clin. Belg. 62, 68-69
22. Gonzalez-Navarro, H, Vila-Caballer, M., Pastor, M. F., Vinue, A., White, M. F., Burks, D., and Andres, V. (2007) Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice. Front. Biosci. 12, 2291-2298
23. Mai, J., Virtue, A., Shen, J., Wang, H, and Yang, X. F. (2013) An evolving new paradigm: endothelial cells-conditional innate immune cells. J. Hematol. Oncol. 6, 61
24. Chowienczyk, P. J., and Watts., G. F., Cockcroft, J. R., and Ritter, J. M. (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340, 1430-1432
25. Madhur, M. S., and Funt., S. A., Li, L., Vinh, A., Chen, W., and Lob., H. E., Iwakura, Y., Blinder, Y., Rahman, A., and Quyyumi., A. A., and Harrison, D. G. (2011) Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31, 1565-1572
26. Butcher, M. J., Gjurich, B. N, Phillips, T., and Galkina, E. V. (2012) The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circ. Res. 110, 675-687
27. Danzaki, K., Matsui, Y., Ikesue, M., Ohta, D., Ito, K., Kanayama, M., Kurotaki, D., Morimoto, J., Iwakura, Y., Yagita, H., Tsutsui, H, and Uede, T. (2012) Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 32, 273-280
28. Kuida, K., and Lippke., J. A., Ku, G., Harding, M. W., and Livingston., D. J., Su, M. S., and Flavell, R. A. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000-2003
29. Wang, H, Jiang, X., Yang, F., Gaubatz, J. W., Ma, L., and Magera., M. J., Yang, X., Berger, P. B., Durante, W., and Pownall., H. J., and Schafer, A. I. (2003) Hyperhomocysteinemia accelerates atherosclerosis in cystathionine β-synthase and apolipoprotein e double knock-out mice with and without dietary perturbation. Blood 101, 3901-3907
30. Ford, E. S., Giles, W. H, and Mokdad, A. H. (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27, 2444-2449
31. Yang, Y., Yang, F., Xiong, Z., Yan, Y., Wang, X., Nishino, M., Mirkovic, D., Nguyen, J., Wang, H., and Yang, X. F. (2005) An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene 24, 4778-4788
32. Yang, X. F., and Wu., C. J., McLaughlin, S., Chillemi, A., Wang, K. S., Canning, C., and Alyea., E. P., Kantoff, P., Soiffer, R. J., Dranoff, G., and Ritz, J. (2001) CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. U.S.A. 98, 7492-7497
33. Li, X., Mai, J., Virtue, A., Yin, Y., Gong, R., Sha, X., Gutchigian, S., Frisch, A., Hodge, I., Jiang, X., Wang, H, and Yang, X. F. (2012) IL-35 is a novel responsive anti-inflammatory cytokine - a new system of categorizing anti-inflammatory cytokines. PLoS One 7, e33628
34. Bagher, P., and Segal, S. S. (2011) The mouse cremaster muscle preparation for intravital imaging of the microcirculation. J. Vis. Exp. 2874
35. Smith, E., and Prasad., K. M., Butcher, M., Dobrian, A., Kolls, J. K., Ley, K., and Galkina, E. (2010) Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121, 1746-1755
36. Mai, J., Wang, H., and Yang, X. F. (2010) Th 17 cells interplay with foxp3+ Tregs in regulation of inflammation and autoimmunity. Front. Biosci. 15, 986-1006
37. Ley, K., Mestas, J., Pospieszalska, M. K., Sundd, P., Groisman, A., and Zarbock, A. (2008) Chapter 11. Intravital microscopic investigation of leukocyte interactions with the blood vessel wall. Methods Enzymol. 445, 255-279
38. Ma, X., and Reynolds., S. L., Baker, B. J., Li, X., Benveniste, E. N., and Qin, H. (2010) IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J. Immunol. 184, 4898-4906
39. Roussel, L., Houle, F., Chan, C, Yao, Y., Bérubé, J., Olivenstein, R., and Martin., J. G., Huot, J., Hamid, Q., Ferri, L., and Rousseau, S. (2010) IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J. Immunol. 184, 4531-4537
40. Arthur, J. S., and Ley, S. C. (2013) Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679-692
41. Anter, E., Chen, K., Shapira, O.M., Karas, R. H, and Keaney, J.F., Jr. (2005) p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor α-dependent pathway in response to black tea polyphenols. Circ. Res. 96, 1072-1078
42. Pober, J. S., and Sessa, W. C. (2007) Evolving functions of endothelial cells in inflammation. Nat Rev. Immunol. 7, 803-815
43. Nguyen, H, and Chiasson., V. L., Chatterjee, P., Kopriva, S. E., and Young., K. J., and Mitchell, B. M. (2013) Interleukin-17 causes rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc. Res. 97, 696-704
44. Gong, F., Liu, Z., Liu, J., Zhou, P., Liu, Y., and Lu, X. (2015) The paradoxical role of IL-17 in atherosclerosis. Cell. Immunol. 297, 33-39
45. Taleb, S., Tedgui, A., and Mallat, Z. (2015) IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Arterioscler. Thromb. Vasc. Biol. 35, 258-264
46. Yang, X. F., Yin, Y., and Wang, H. (2008) Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory t cells. Drug Discov. Today Ther. Strateg. 5, 125-142
47. Chen, S., Shimada, K., Zhang, W., Huang, G., and Crother., T. R., and Arditi, M. (2010) IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J. Immunol. 185, 5619-5627
48. Shalom-Barak, T., Quach, J., and Lotz, M. (1998) Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-ΚB. J. Biol. Chem. 273, 27467-27473
49. Surendar, J., Aravindhan, V., Rao, M. M., Ganesan, A., and Mohan, V. (2011) Decreased serum interleukin-17 and increased transforming growth factor-β levels in subjects with metabolic syndrome (Chennai Urban Rural Epidemiology Study-95). Metabolism 60, 586-590